Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors

Clinical trial NCT05235607 · UNKNOWN

Trial details

NCT number: NCT05235607
Sponsor: Sichuan University
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Carcinoma Melanoma Bladder Cancer Colorectal Cancer

Start date: 2022-03-01
Primary completion: 2023-06-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.